Biotech Values

[genisi]

ANA598 - data at 4 weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study:

http://www.anadyspharma.com/pr_pdfs/ana598%204-week%20interim%20results%20final%2012.17.09.pdf

Still a difference between genotypes 1a and 1b but what looks strange here is that VL change was quite similar in genotype 1b and placebo 3.7 and 3.9 (log10 IU/ml) respectively.